Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
An initial study on the effect of functional electrical stimulation in erectile dysfunction: a randomized controlled
Cristiane Carboni1, Alexandre Fornari2, Karoline C Bragante2
1Department of Health Science and Rehabilitation, Federal University of Health Sciences of Porto Alegre-UFCSPA, Porto Alegre, Rio Grande do Sul, Brazil. criscarboni@hotmail.com.
Functional electrical stimulation (FES) therapy improved erectile function and quality of life in men with erectile dysfunction (ED). This regenerative treatment option showed significant benefits compared to placebo in a randomized clinical trial.
Area of Science:
- Urology
- Regenerative Medicine
- Clinical Trials
Background:
- Erectile dysfunction (ED) affects millions globally, with smooth muscle cell degeneration being a common cause.
- Functional electrical stimulation (FES) therapy demonstrates significant regenerative potential for smooth muscle cells.
- FES is emerging as a promising treatment for ED, particularly when linked to cavernous smooth muscle degeneration.
Purpose of the Study:
- To investigate the efficacy of FES therapy in improving erectile function in men diagnosed with ED.
- To assess the impact of FES on the quality of life for patients experiencing erectile dysfunction.
Main Methods:
- A randomized clinical trial involving 22 male participants with ED, assigned to either an intervention group (IG) or a control group (CG).
- The IG received FES therapy (50 Hz/500 µs) for 4 weeks (two 15-minute sessions/week) at sub-motor threshold intensity.
- The CG received placebo FES, adhering to the same treatment schedule. Erectile function was evaluated using the IIEF-5 and EHS, and quality of life using the WHOQOL questionnaire.
Main Results:
- Statistically significant improvements in the International Index of Erectile Function (IIEF-5) and Erection Hardness Score (EHS) were observed in the FES group compared to the placebo group (p < 0.05).
- The FES group showed significant within-group improvements in IIEF-5 and EHS post-treatment (p < 0.0001).
- Quality of life, assessed by the WHOQOL, significantly improved in the FES group compared to the control group (p < 0.05) and within the FES group (p < 0.0001), excluding the Environment domain.
Conclusions:
- FES therapy is a potentially effective treatment for improving erectile function in men with ED.
- FES therapy may significantly enhance the quality of life for individuals suffering from erectile dysfunction.
- The findings support FES as a beneficial therapeutic option for ED related to smooth muscle degeneration.
More Related Videos
04:22Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Initiation of Translation
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Transfer Function in Control Systems
To derive the transfer function, consider a general nth-order linear time-invariant...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Trial and Error and Algorithm